BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10541877)

  • 1. Tumor markers in peripheral blood of patients with malignant melanoma: multimarker RT-PCR versus a luminoimmunometric assay for S-100.
    Berking C; Schlüpen EM; Schrader A; Atzpodien J; Volkenandt M
    Arch Dermatol Res; 1999 Sep; 291(9):479-84. PubMed ID: 10541877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method.
    Arenberger P; Arenbergerova M; Gkalpakiotis S; Lippert J; Stribrna J; Kremen J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):56-64. PubMed ID: 18181974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum protein s-100 predicts clinical outcome in patients with melanoma treated with adjuvant interferon--comparison with tyrosinase rt-PCR.
    Domingo-Domènech J; Molina R; Castel T; Montagut C; Puig S; Conill C; Martí R; Vera M; Auge JM; Malvehy J; Grau JJ; Gascon P; Mellado B
    Oncology; 2005; 68(4-6):341-9. PubMed ID: 16020961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
    Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate.
    Davids V; Kidson SH; Hanekom GS
    Mol Pathol; 2003 Feb; 56(1):43-51. PubMed ID: 12560463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma.
    Hasselmann DO; Rappl G; Rössler M; Ugurel S; Tilgen W; Reinhold U
    Oncol Rep; 2001; 8(1):115-8. PubMed ID: 11115581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gp100 mRNA is more sensitive than tyrosinase mRNA for RT-PCR amplification to detect circulating melanoma cells in peripheral blood of melanoma patients.
    Tsukamoto K; Ueda M; Hirata S; Osada A; Kitamura R; Takahashi T; Ichihashi M; Shimada S
    J Dermatol Sci; 2000 Jun; 23(2):126-31. PubMed ID: 10808130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
    Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
    Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
    Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA
    Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of PCR-positive mRNA markers in peripheral blood and regional nodes of malignant melanoma patients. Melanoma Cooperative Group.
    Palmieri G; Pirastu M; Strazzullo M; Ascierto PA; Satriano SM; Motti ML; Botti G; Mozzillo N; Castello G; Cossu A; Lissia A; Tanda F
    Recent Results Cancer Res; 2001; 158():200-3. PubMed ID: 11092047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled--polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma.
    Brownbridge GG; Gold J; Edward M; MacKie RM
    Br J Dermatol; 2001 Feb; 144(2):279-87. PubMed ID: 11251559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients.
    Koyanagi K; Kuo C; Nakagawa T; Mori T; Ueno H; Lorico AR; Wang HJ; Hseuh E; O'Day SJ; Hoon DS
    Clin Chem; 2005 Jun; 51(6):981-8. PubMed ID: 15817820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymerase chain reaction in the detection of circulating tumour cells in peripheral blood of melanoma patients.
    Schittek B; Blaheta HJ; Ellwanger U; Garbe C
    Recent Results Cancer Res; 2001; 158():93-104. PubMed ID: 11092036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay.
    Palmieri G; Ascierto PA; Cossu A; Mozzillo N; Motti ML; Satriano SM; Botti G; Caracò C; Celentano E; Satriano RA; Lissia A; Tanda F; Pirastu M; Castello G;
    J Clin Oncol; 2001 Mar; 19(5):1437-43. PubMed ID: 11230489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.
    Palmieri G; Strazzullo M; Ascierto PA; Satriano SM; Daponte A; Castello G
    J Clin Oncol; 1999 Jan; 17(1):304-11. PubMed ID: 10458247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.
    Kunter U; Buer J; Probst M; Duensing S; Dallmann I; Grosse J; Kirchner H; Schluepen EM; Volkenandt M; Ganser A; Atzpodien J
    J Natl Cancer Inst; 1996 May; 88(9):590-4. PubMed ID: 8609659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity for the detection of malignant melanoma cells in peripheral blood using an improved protocol for reverse transcription-polymerase chain reaction.
    Schittek B; Blaheta HJ; Flörchinger G; Sauer B; Garbe C
    Br J Dermatol; 1999 Jul; 141(1):37-43. PubMed ID: 10417513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors.
    Proebstle TM; Jiang W; Högel J; Keilholz U; Weber L; Voit C
    Br J Cancer; 2000 Jan; 82(1):118-23. PubMed ID: 10638977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of melanoma cell-specific MART-1 mRNA in peripheral blood by a calibrated competitive reverse transcription-PCR.
    Sørensen BS; Schmidt H; von der Maase H; Straten PT; Nexø E
    Clin Chem; 2000 Dec; 46(12):1923-8. PubMed ID: 11106324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood.
    Pittman K; Burchill S; Smith B; Southgate J; Joffe J; Gore M; Selby P
    Ann Oncol; 1996 Mar; 7(3):297-301. PubMed ID: 8740795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.